Search research articles
Contact Us
Filters
Showing results (21-30 of 38) with videos related to
Page
of 4
Sort By:
Cancer Immunology Research
|
January 21, 2015
Requirement for innate immunity and CD90⁺ NK1.1⁻ lymphocytes to treat established melanoma with chemo-immunotherapy
Marina Moskalenko, Michael Pan, Yichun Fu, et al.
The Journal of Clinical Investigation
|
June 15, 2011
Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma
Miriam Benezra, Oula Penate-Medina, Pat B Zanzonico, et al.
Melanoma Research
|
January 23, 2016
A phase 2 trial of everolimus and pasireotide long-acting release in patients with metastatic uveal melanoma
Alexander N Shoushtari, Leonard T Ong, Heiko Schoder, et al.
Journal for Immunotherapy of Cancer
|
November 20, 2021
Treatment-free survival over extended follow-up of patients with advanced melanoma treated with immune checkpoint inhibitors in CheckMate 067
Meredith M Regan, Charlene M Mantia, Lillian Werner, et al.
Oncotarget
|
June 22, 2016
The metabolic/pH sensor soluble adenylyl cyclase is a tumor suppressor protein
Lavoisier Ramos-Espiritu, Ana Diaz, Charlee Nardin, et al.
Journal for Immunotherapy of Cancer
|
November 18, 2021
Efficacy and safety of vedolizumab and infliximab treatment for immune-mediated diarrhea and colitis in patients with cancer: a two-center observational study
Fangwen Zou, David Faleck, Anusha Thomas, et al.
Journal for Immunotherapy of Cancer
|
January 25, 2022
Ipilimumab alone or in combination with nivolumab in patients with advanced melanoma who have progressed or relapsed on PD-1 blockade: clinical outcomes and translational biomarker analyses
Claire F Friedman, Christine Spencer, Christopher R Cabanski, et al.
Kidney International
|
June 11, 2016
Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitors
Frank B Cortazar, Kristen A Marrone, Megan L Troxell, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 27, 2017
Health-related quality of life results from the phase III CheckMate 067 study
Dirk Schadendorf, James Larkin, Jedd Wolchok, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
March 2, 2017
Patient perspectives on ipilimumab across the melanoma treatment trajectory
Elyse Shuk, Alexander N Shoushtari, Jason Luke, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 38) with videos related to
Sort By:
Page
of 4
Cancer Immunology Research
|
January 21, 2015
Requirement for innate immunity and CD90⁺ NK1.1⁻ lymphocytes to treat established melanoma with chemo-immunotherapy
Marina Moskalenko, Michael Pan, Yichun Fu, et al.
The Journal of Clinical Investigation
|
June 15, 2011
Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma
Miriam Benezra, Oula Penate-Medina, Pat B Zanzonico, et al.
Melanoma Research
|
January 23, 2016
A phase 2 trial of everolimus and pasireotide long-acting release in patients with metastatic uveal melanoma
Alexander N Shoushtari, Leonard T Ong, Heiko Schoder, et al.
Journal for Immunotherapy of Cancer
|
November 20, 2021
Treatment-free survival over extended follow-up of patients with advanced melanoma treated with immune checkpoint inhibitors in CheckMate 067
Meredith M Regan, Charlene M Mantia, Lillian Werner, et al.
Oncotarget
|
June 22, 2016
The metabolic/pH sensor soluble adenylyl cyclase is a tumor suppressor protein
Lavoisier Ramos-Espiritu, Ana Diaz, Charlee Nardin, et al.
Journal for Immunotherapy of Cancer
|
November 18, 2021
Efficacy and safety of vedolizumab and infliximab treatment for immune-mediated diarrhea and colitis in patients with cancer: a two-center observational study
Fangwen Zou, David Faleck, Anusha Thomas, et al.
Journal for Immunotherapy of Cancer
|
January 25, 2022
Ipilimumab alone or in combination with nivolumab in patients with advanced melanoma who have progressed or relapsed on PD-1 blockade: clinical outcomes and translational biomarker analyses
Claire F Friedman, Christine Spencer, Christopher R Cabanski, et al.
Kidney International
|
June 11, 2016
Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitors
Frank B Cortazar, Kristen A Marrone, Megan L Troxell, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 27, 2017
Health-related quality of life results from the phase III CheckMate 067 study
Dirk Schadendorf, James Larkin, Jedd Wolchok, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
March 2, 2017
Patient perspectives on ipilimumab across the melanoma treatment trajectory
Elyse Shuk, Alexander N Shoushtari, Jason Luke, et al.
Page
of 4